Last reviewed · How we verify

NCT06930898

Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform

Completed NA Last updated 18 April 2025
What this trial tests

NA trial testing Gamified Mammoverse Platform in Health Education in 72 participants. Completed in 24 March 2025.

Timeline
1 December 2024
Primary endpoint
1 February 2025
24 March 2025

Quick facts

Lead sponsorUniversity of Malaya
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment72
Start date1 December 2024
Primary completion1 February 2025
Estimated completion24 March 2025
Sites2 locations across China, Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

University of Malaya

Who can join

Adults 18 to 65, female only, with Health Education or Breast Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aimed to evaluate the effectiveness of Mammoverse, a gamified metaverse-based educational platform, in improving breast health knowledge among women in China. Participants were randomly assigned to either a gamified or non-gamified version of the platform. Both groups received identical educational content, but only the gamified group experienced interactive game elements such as avatars, progress feedback, and rewards. Knowledge was assessed at baseline, immediately post-intervention, and at 4-week follow-up. The study found that the gamified platform significantly improved knowledge retention and participant engagement compared to the non-gamified version. This ClinicalTrials.gov registration reflects only the randomized controlled trial (RCT) portion of a broader mixed-methods study that was approved by the University of Malaya Research Ethics Committee (Ref: UM.TNC2/UMREC\_3967). The full study protocol includes three methodological approaches, and this registration pertains specifically to the RCT component involving the Mammoverse platform. Other study components are not included in this registration.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Gamified Versus Nongamified Metaverse Learning for Breast Health Knowledge in Women: Randomized Controlled Trial.
    Li R, Kahn SM, Duan B, Wong SY. · · 2026 · PMID 41687006 · DOI 10.2196/75318
  2. A gamified metaverse platform (Mammoverse) for breast health education: A mixed-methods study.
    Li R, Wong SY, Duan B, Kahn SM. · · 2025 · PMID 41170177 · DOI 10.1177/20552076251390466

Verify or expand the search:

Other recruiting trials for Health Education

Currently open trials in the same condition.

Other University of Malaya trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06930898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing